The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

25 Jan 2018 07:00

RNS Number : 8611C
Quixant PLC
25 January 2018
 

25 January 2018

Quixant plc

("Quixant" or the "Group")

 

Trading Update and Notice of Results

 

Quixant (AIM: QXT), a leading provider of innovative, highly engineered technology products principally to the global gaming industry, is pleased to provide the following update on trading for the year ended 31 December 2017.

 

The Board of Quixant is pleased to announce that it expects to report revenue for the twelve months ending 31 December 2017 of approximately $109m, an increase of 20% over the prior period. The Board also expects to report adjusted profit before tax in line with market expectations despite a $1.6m write off in relation to a loss resulting from the substitution of a component incorporated into several of our products. Net cash at 31 December 2017 was approximately $4.2m.

 

The Group's results for the full year to 31 December 2017 are expected to be announced on 22 March 2018.

 

Jon Jayal, COO of Quixant, commented:

 

"This has been another very good year of growth for the business, with a particularly strong performance in our core gaming platforms and gaming monitors. Densitron has also performed well as we continue to rationalise its product range to focus on higher margin business.

 

"I suggested in our interim results the full year was likely to be first half weighted and this has proved to be the case. Despite historically being second half weighted, as the Group continues to grow the customer book and broaden the product range we are moving towards a more balanced weighting split.

 

"During the year we have invested in the business with a number of senior management appointments and a circa 20% increase in the total number of employees. As a result, we are well positioned to continue to grow the Group over the long term."

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

 

For further information please contact:

 

Quixant plc

Tel: +44 (0)1223 892 696

Jon Jayal, Chief Operating Officer

Nominated Adviser and Broker:

finnCap Ltd

Tel: +44(0)20 7220 0500

Matt Goode / Henrik Persson / Simon Hicks (Corporate Finance)

Simon Johnson / Alice Lane (Corporate Broking)

Financial PR:

Tel: +44(0)20 8004 4217

Alma PR

John Coles / Hilary Buchanan / Susie Hudson

 

About Quixant

 

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming industry. The Company is headquartered in Cambridge in the UK where the global sales function is based. North America sales and sales support is run from their subsidiary in Las Vegas. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support team based in Italy. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP some of which is protected by patents and design rights.

 

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets. In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMGZMZDVGRZZ
Date   Source Headline
11th Jun 20193:00 pmRNSHolding(s) in Company
21st May 20194:39 pmRNSHolding(s) in Company
3rd May 201911:07 amRNSDirector/PDMR Shareholding
1st May 20194:09 pmRNSGrant of Options
1st May 20194:03 pmRNSExercise of Options
18th Apr 20194:49 pmRNSExercise of Options
16th Apr 201911:13 amRNSResult of AGM
10th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20195:57 pmRNSGrant of Options
4th Apr 20191:54 pmRNSGrant of Options
27th Mar 20197:00 amRNSDirector/PDMR Shareholding
25th Mar 20197:00 amRNSFinal Results
24th Jan 20197:00 amRNSTrading Update and Notice of Results
21st Jan 20192:51 pmRNSHolding(s) in Company
4th Jan 201910:13 amRNSBoard Change
22nd Oct 20189:41 amRNSIssue of Equity & PDMR Dealing
5th Oct 20185:50 pmRNSIssue of Options & Director/PDMR Dealings
21st Sep 20187:40 amRNSHolding(s) in Company
19th Sep 20187:00 amRNSHalf-year Report
19th Jul 20187:00 amRNSTrading Update and Notice of Results
4th Jul 20184:36 pmRNSDirector/PDMR Shareholding
14th May 20188:07 amRNSHolding(s) in Company
11th May 20184:10 pmRNSDirector/PDMR Dealings
30th Apr 20187:00 amRNSDirector/PDMR Shareholdings
27th Apr 20182:15 pmRNSResult of placing in Quixant plc
27th Apr 20189:50 amRNSProposed placing in Quixant plc
24th Apr 201811:14 amRNSResult of AGM
5th Apr 20183:23 pmRNSGrant of Options
26th Mar 20184:18 pmRNSDividend Timetable
22nd Mar 20187:00 amRNSFinal Results
1st Mar 20187:00 amRNSBoard Changes and Appointment of CFO
2nd Feb 201810:08 amRNSHolding(s) in Company
25th Jan 20187:00 amRNSTrading Update and Notice of Results
28th Nov 20171:59 pmRNSDirector/PDMR Shareholding
27th Oct 20175:15 pmRNSIssue of Equity and Director/PDMR Shareholding
4th Oct 20172:23 pmRNSHolding(s) in Company
21st Sep 20177:03 amRNSHolding(s) in Company
21st Sep 20177:00 amRNSHalf-year Report
11th Sep 20173:00 pmRNSHolding(s) in Company
22nd Aug 201710:16 amRNSHolding(s) in Company
7th Aug 20177:00 amRNSNotice of Results
24th Jul 20177:00 amRNSTrading Update and Notice of Results
13th Jul 201710:25 amRNSHolding(s) in Company
2nd Jun 20178:00 amRNSDirector/PDMR Shareholding
12th May 20174:55 pmRNSDirector/PDMR Shareholding
4th May 20172:37 pmRNSIssue of Equity and Director/PDMR Dealings
25th Apr 201712:15 pmRNSResult of AGM
22nd Mar 201712:00 pmRNSBoard Appointment
22nd Mar 201710:00 amRNSDividend Timetable
22nd Mar 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.